Mirum Pharmaceuticals (MIRM) Current Leases (2019 - 2024)
Mirum Pharmaceuticals' quarterly Current Leases came in at $1.7 million in Q4 2024, up 54.8% year-on-year from $1.1 million in Q1 2024, and up 13.48% quarter-over-quarter from $1.5 million in Q3 2024.
Mirum Pharmaceuticals has reported Current Leases for 6 years, with the latest figure at $1.7 million in Q4 2024.
- For the quarter ending Q4 2024, Current Leases rose 54.8% year-over-year to $1.7 million; the trailing twelve-month figure through Dec 2024 stood at $1.7 million (up 54.8% YoY), and the FY2024 full-year result was $1.7 million, up 54.8% from the prior year.
- Current Leases for Q4 2024 stood at $1.7 million, up from $1.5 million in the prior quarter.
- The five-year high for Current Leases was $1.7 million in Q4 2024, with the low at $358000.0 in Q1 2024.
- Average Current Leases over 5 years is $850800.0, with a median of $741500.0 recorded in 2022.
- Year-over-year, Current Leases surged 139.82% in 2020 and tumbled 60.83% in 2024.
- Tracing MIRM's Current Leases over 5 years: stood at $636000.0 in 2020, then rose by 11.79% to $711000.0 in 2021, then soared by 30.94% to $931000.0 in 2022, then gained by 18.58% to $1.1 million in 2023, then jumped by 54.8% to $1.7 million in 2024.
- The last three Current Leases figures came in at $1.7 million (Q4 2024), $1.5 million (Q3 2024), and $1.1 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Mirum Pharmaceuticals | 5.97 Bn | 5.59 Bn | 131.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.71 Mn |
| Sep 30, 2024 | 1.51 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 358,000.00 |
| Dec 31, 2023 | 1.10 Mn |
| Sep 30, 2023 | 1.08 Mn |
| Jun 30, 2023 | 1.06 Mn |
| Mar 31, 2023 | 914,000.00 |
| Dec 31, 2022 | 931,000.00 |
| Sep 30, 2022 | 775,000.00 |
| Jun 30, 2022 | 752,000.00 |
| Mar 31, 2022 | 731,000.00 |
| Dec 31, 2021 | 711,000.00 |
| Sep 30, 2021 | 690,000.00 |
| Jun 30, 2021 | 671,000.00 |
| Mar 31, 2021 | 653,000.00 |
| Dec 31, 2020 | 636,000.00 |
| Sep 30, 2020 | 616,000.00 |
| Jun 30, 2020 | 530,000.00 |
| Mar 31, 2020 | 511,000.00 |
| Dec 31, 2019 | 397,000.00 |
| Sep 30, 2019 | 332,000.00 |
| Jun 30, 2019 | 221,000.00 |